Allosteric modulation of the muscarinic M <sub>4</sub> receptor as an approach to treating schizophrenia
Wai‐Yee Chan(Chinese University of Hong Kong), Christian C. Felder(National Institutes of Health), Arthur Christopoulos(Australian Research Council), N.J.M. Birdsall(The Francis Crick Institute), Suchira Bose, David L. McKinzie, Sebastian Lazareno(LifeArc), Jeffrey M. Witkin(St Vincent Hospital), R. C. Thompson(Imperial College London), S.N. Mitchell, Frank P. Bymaster
Cited by 237
Related Papers
International Union of Pharmacology. XVII. Classification of Muscarinic Acetylcholine Receptors
|Pharmacological Reviews|1998|1.5k
Muscarinic Receptor Subtypes
|The Annual Review of Pharmacology and Toxicology|1990|1.3k
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
The Binding of Agonists to Brain Muscarinic Receptors
|Molecular Pharmacology|1978|676